Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin

American Journal of Reproductive Immunology

Volumn 54, Issue 6, 2005, Pages 390-396

  Stricker, Raphael B ^a   Winger, Edward E ^b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

Abortion; Autoimmunity; Intravenous immunoglobulin; Miscarriage; Natural killer cells

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; ALLERGIC REACTION; ARTICLE; CLINICAL TRIAL; CONCEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ECTOPIC PREGNANCY; FEMALE; FETUS DISEASE; GESTATIONAL AGE; HEADACHE; HUMAN; IMMUNOLOGY; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTIVE SUCCESS; SPONTANEOUS ABORTION; TREATMENT REFUSAL;

ABORTION, HABITUAL; ADULT; AUTOANTIBODIES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES;

EID: 28644441380     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2005.00335.x     Document Type: Article

References (42)

1. Stephenson MD, Dreher K, Houlihan E, Wu V: Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial. Am J Reprod Immunol 1998; 39:82-88.
2. Christiansen OB: Intravenous immunoglobulin in the prevention of recurrent spontaneous abortion: the European experience. Am J Reprod Immunol 1998; 39:77-81.
3. Daya S, Gunby J, Clark DA: Intravenous immunoglobulin therapy for recurrent spontaneous abortion: a meta-analysis. Am J Reprod Immunol 1998; 39:69-76.
4. Balasch J, Creus M, Fabregues F, Font J, Martorell J, Vanrell JA: Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer. Fertil Steril 1996; 65:655-658.
5. Templeton A, Morris JK, Parslow W: Factors that affect outcome of in vitro fertilisation treatment. Lancet 1996; 348:1402-1406.
6. Gleicher N, Friberg J: IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters. JAMA 1985; 253:3278-3281.
7. Xu L, Chang V, Murphy A, Rock JA, Damewood M, Schlaff W, Zacur HA: Antinuclear antibodies in sera of patients with recurrent pregnancy wastage. Am J Obstet Gynecol 1990; 163:1493-1497.
8. Stagnaro-Green A, Roman SH, Cobin RH, El-Harazy E, Alvarez-Marfany M, Davies TF: Detection of at-risk pregnancy by means of highly sensitive assays for thyroid antibodies. JAMA 1990; 264:1422-1425.
9. Maier DB, Parke A: Subclinical autoimmunity in recurrent aborters. Fertil Steril 1989; 51:280-286.
10. Silver RM, Branch DW: Recurrent miscarriage: autoimmune considerations. Clin Obstet Gynecol 1994; 37:745-760.
11. Coulam CB, Goodman C, Roussev RG, Thomason EJ, Beaman KD: Systemic CD56+ cells can predict pregnancy outcome. Am J Reprod Immunol 1995; 33:40-46.
12. Hill JA, Polgar K, Anderson DJ: T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995; 273:1933-1936.
13. Lachapelle MH, Miron P, Hemmings R, Roy DC: Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. J Immunol 1996; 156:4027-4034.
14. Haddad EK, Duclos AJ, Lapp WS, Baines MG: Early embryo loss is associated with the prior expression of macrophage activation markers in the decidua. J Immunol 1997; 158:4886-4891.
15. Rand JR, Wu X-X, Andree HAM, Lockwood CJ, Guller S, Scher J, Harpel PC. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 1997; 337:154-160.
16. Blank M, Cohen J, Toder V, Shoenfeld Y: Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies. Proc Natl Acad Sci U S A 1991; 88:3069-3073.
17. Rosove MH, Tabsh K, Wasserstrum N, Howard P, Hahn BH, Kalunian KC: Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990; 75:630-635.
18. Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174:1584-1589.
19. Lecuru F, Desnos M, Taurelle R: Anticoagulant therapy during pregnancy. Acta Obstet Gynecol Scand 1996; 75:217-221.
20. CDC. Pregnancy-related death associated with heparin and aspirin treatment for infertility, 1996. MMWR 1998; 47:368-371.
21. Laskin CA, Bombardier C, Hannah ME, Mandel FP, Ritchie JW, Farewell V, Farine D, Spitzer K, Fielding L, Soloninka CA, Yeung M: Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997; 337:148-153.
22. Fraser EJ, Grimes DA, Schulz KF: Immunization as therapy for recurrent spontaneous abortion: a review and meta-analysis. Obstet Gynecol 1993; 82:854-859.
23. Gafter U, Sredni B, Segal J, Kalechman Y: Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion. J Clin Immunol 1997; 17:408-419.
24. Coulam CB, Stephenson M, Stern JJ, Clark DA: Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials. Am J Reprod Immunol 1996; 35:352-359.
25. Kiprov DD, Nachtigall RD, Weaver RC, Jacobson A, Main EK, Garovoy MR: The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol 1996; 36:228-234.
26. Coulam CB, Krysa LW, Bustillo M: Intravenous immunoglobulin for in-vitro fertilization failure. Hum Reprod 1994; 9:2265-2269.
27. German RSA/IVIG Group. Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J Obstet Gynaecol 1994; 101:1072-1077.
28. Christiansen OB, Mathieson O, Husth M, Rasmussen KL, Ingerslev HJ, Lauritsen JG, Grunnet N: Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin. Hum Reprod 1995; 10:2690-2695.
29. Stricker RB, Steinleitner A, Winger EE: Intravenous immunoglobulin therapy for immunologic abortion. Clin Appl Immunol Rev 2002; 2:187-199.
30. Reid TMS: Striking a balance in maternal immune response to infection. Lancet 1998; 351:1670-1671.
31. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S: Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998; 4:1020-1024.
32. Sacks G, Sargent I, Redman C: An innate view of human pregnancy. Immunol Today 1999; 20:114-118.
33. Coulam CB, Clark DA: Immunotherapy for recurrent abortion. Am J Reprod Immunol 1994; 32:257-260.
34. Ruiz JE, Kwak JYH, Baum L, Gilman-Sachs A, Beaman KD, Kim YB, Beer AE: Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion. Am J Reprod Immunol 1996; 35:370-375.
35. Kwak JYH, Kwak FMY, Ainbinder SW, Ruiz AM, Beer AE: Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996; 35:363-369.
36. Rigal D, Vermot-Desroches C, Heitz S, Bernaud J, Alfonsi F, Monier JC: Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, NK, and T cell subpopulations in women with recurrent spontaneous abortions: specific effects on LFA-1 and CD56 molecules. Clin Immunol Immunopathol 1994; 71:309-314.
37. Prasad NKA, Papoff G, Zeuner A, Bonnin E, Kazatchkine MD, Ruberti G, Kaveri SV: Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J Immunol 1998; 161:3781-3790.
38. Zhang R, Szerlip HM: Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy. South Med J 2000; 93:901-904.
39. Concato J, Shah N, Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342:1887-1892.
40. Benson K, Hartz AJ: A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342:1878-1886.
41. Ioannidis JPA, Haidich AB, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, Contopoulos-Ioannidis DG, Lau J: Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001; 286:821-830.
42. Sher G, Fisch JD: 'In silico experiments' - yes, but the great western cowboy 'random chance' is still alive. Fertil Steril 2001; 76:636-637.